LG-888

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameLG-888
Drug Alias NameFactor VIII agonist (Lentigen)coagulation stimulator (Lentigen)LG-888
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionCoagulation factor VIII stimulants
TargetsCoagulation factor VIII
Therapy Area/IndicationsHemophilia A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLentigen Technology Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesExpression Therapeutics LlcEmory UniversityLentigen Technology Inc
Active IndicationsN/A
Inactive IndicationsHemophilia A

Other Information

ATC CodeN/A
Related LinksN/A